Evidence map›Paper›PMID 34286847›Full record

SynthesisJournal of Crohn's & colitis2022

Transcriptome-Wide Association Study for Inflammatory Bowel Disease Reveals Novel Candidate Susceptibility Genes in Specific Colon Subsites and Tissue Categories.

Virginia Díez-Obrero, Ferran Moratalla-Navarro, Gemma Ibáñez-Sanz, Jordi Guardiola, Francisco Rodríguez-Moranta, Mireia Obón-Santacana, Anna Díez-Villanueva, Christopher Heaton Dampier, Matthew Devall, Robert Carreras-Torres and 2 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of Crohn's & colitis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System.International journal of molecular sciences · 2023
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Virginia Díez-ObreroOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Ferran Moratalla-NavarroOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Gemma Ibáñez-SanzOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Jordi GuardiolaGastroenterology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-0464-241X
Francisco Rodríguez-MorantaGastroenterology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.
Mireia Obón-SantacanaOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Anna Díez-VillanuevaOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Christopher Heaton DampierCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Matthew DevallCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0001-5943-4397
Robert Carreras-TorresOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Graham CaseyCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Victor MorenoOncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-2818-5487
Institut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ESUniversity of Virginia · USInstitut Català d'Oncologia · ES

Funding

Using Functional Genomics to Inform Gene Environment Interactions for Colorectal CancerR01CA201407 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GAUDERMAN, WILLIAM JAMES, LE MARCHAND, LOIC · 2016 to 2020
$9.6M
Inherited colorectal cancer risk variants: from association to biologyR01CA143237 · NCI · UNIVERSITY OF VIRGINIA · PI CASEY, GRAHAM · 2010 to 2020
$8.4M
Postdoctoral Training Grant for MDs in Surgical Oncology ResearchT32CA163177 · NCI · UNIVERSITY OF VIRGINIA · PI Craig Lee Slingluff, Allan Tsung · 2011 to 2026
$4.6M
Biology of Colorectal Cancer Risk EnhancersR01CA204279 · NCI · UNIVERSITY OF VIRGINIA · PI CASEY, GRAHAM, SCACHERI, PETER CHRISTOPHER · 2016 to 2020
$3.0M
Agency for Management of University and Research Grants 2017SGR723Centro de investigación biomédica en red CB07/02/2005Instituto de Salud Carlos III PI14-00613Ministerio de Educación, Cultura y Deporte FPU16/00599NCI NIH HHS R01 CA143237NCI NIH HHS R01 CA201407NCI NIH HHS R01 CA204279NCI NIH HHS T32 CA163177NIH HHS R01 CA204279Spanish Association Against Cancer GCTRA18022MORE
6 · The paper itself

Abstract

BACKGROUND AND

aimsGenome-wide association studies [GWAS] for inflammatory bowel disease [IBD] have identified 240 risk variants. However, the benefit of understanding the genetic architecture of IBD remains to be exploited. Transcriptome-wide association studies [TWAS] associate gene expression with genetic susceptibility to disease, providing functional insight into risk loci. In this study, we integrate relevant datasets for IBD and perform a TWAS to nominate novel genes implicated in IBD genetic susceptibility.

methodsWe applied elastic net regression to generate gene expression prediction models for the University of Barcelona and University of Virginia RNA sequencing project [BarcUVa-Seq] and correlated expression and disease association research [CEDAR] datasets. Together with Genotype-Tissue Expression project [GTEx] data, and GWAS results from about 60 000 individuals, we employed Summary-PrediXcan and Summary-MultiXcan for single and joint analyses of TWAS results, respectively.

resultsBarcUVa-Seq TWAS revealed 39 novel genes whose expression in the colon is associated with IBD genetic susceptibility. They included expression markers for specific colon cell types. TWAS meta-analysis including all tissues/cell types provided 186 novel candidate susceptibility genes. Additionally, we identified 78 novel susceptibility genes whose expression is associated with IBD exclusively in immune (N = 19), epithelial (N = 25), mesenchymal (N = 22) and neural (N = 12) tissue categories. Associated genes were involved in relevant molecular pathways, including pathways related to known IBD therapeutics, such as tumour necrosis factor signalling.

conclusionThese findings provide insight into tissue-specific molecular processes underlying IBD genetic susceptibility. Associated genes could be candidate targets for new therapeutics and should be prioritized in functional studies.

Indexed as

Genome-Wide Association StudyInflammatory Bowel DiseasesColonGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideTranscriptomegene expressiongenetic susceptibilityTranscriptome-wide association study

Identifiers

PMID34286847
PMCPMC8864630
OpenAlexW3184576429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.